Sentence examples for outcome comes from from inspiring English sources

The quote "peaceful outcome" comes from a security source.

Two-sample Mendelian randomization is a strategy in which evidence on the associations of genetic variants with the risk factor and with the outcome comes from non-overlapping data sources [ 15].

Much of what is known about the prevalence of liver disease in ATD and its outcome comes from a prospective, relatively unbiased study started in Sweden in the 1970s (Piitulainen et al., 2005; Sveger, 1976).

The multiple regression analysis resulted in a 2010 model of mean stage of −0.57 + 0.02*Degree Days + 0.33*I (Valley) − 0.01*Degree Days*I Valley), where I Valley) is 1 when the outcome comes from the Willamette Valley and 0 otherwise.

The first piece of evidence supporting a role for genetic differences in infection risk and outcome came from an epidemiological study reporting a strong association between death from infection in adoptees and their biological, but not adoptive, parents [ 7].

If the genetic associations with the risk factors and with the outcome are measured in the same data set, this will lead to bias in the direction of the observational association (25), whereas if the genetic associations with the risk factors and with the outcome come from different sources (known as a 2-sample instrumental-variable analysis), the bias will be in the direction of the null (26).

The variability of the outcomes comes from within- and inter-subject variabilities.

One possible explanation for the persistence of negative views despite an awareness of the improving outcomes comes from the visual images of cancer.

The strongest evidence for the efficacy of telemedicine in clinical outcomes comes from home-based telemedicine in the areas of chronic disease management, hypertension, and AIDS.

Evidence for beneficial effects of solar ultraviolet-B (UVB) irradiance and vitamin D in reducing the risk of adverse health outcomes comes from a variety of study types: ecological, cross-sectional, case-control, cohort, and intervention.

The greatest contribution to better outcomes comes from advances in our understanding of the genetics of cancer [3], [4], [5], and the discovery of molecular biomarkers and incorporation of novel targeted agents has led to improved outcomes for cancer patients, and decreases in both short- and long-term toxicities [6].